Price target
423.480.00 0.00%
The 5 analysts offering 1 year price forecasts for BIO.B have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to BIO.B in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BIO.B EPS for the last quarter is 3.10 USD despite the estimation of 2.84 USD. In the next quarter EPS is expected to reach 2.17 USD. Track more of Bio-Rad Laboratories, Inc. financials and stay on top of what is up with the company.
In the next quarter Bio-Rad Laboratories, Inc. revenue is expected to reach 616.58 M USD. Check out Bio-Rad Laboratories, Inc. revenue and earnings and make informed decisions.
According to analysts, BIO.B price target is 423.48 USD with a max estimate of 474.00 USD and a min estimate of 350.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with BIO.B news and stock market news.
We've gathered opinions of 6 analysts rating BIO.B stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.